PanGen Biotech Inc. (KOSDAQ: 222110)

PanGen Biotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,245	45.4	838.28	8,901	8,139	4,363
Short-Term Investments	4,002	149.24	2	15,199	10,550	20,000
Cash & Short-Term Investments	5,247	194.65	840.28	24,100	18,689	24,363
Cash Growth	427.13%	-76.84%	-96.51%	28.95%	-23.29%	-15.78%
Accounts Receivable	1,753	2,208	689.81	1,089	535.34	55.88
Other Receivables	20.13	8.54	221.29	241.03	176.87	143.3
Receivables	2,023	2,330	974.1	1,393	775.21	262.18
Inventory	7,672	6,925	6,630	4,373	3,764	799.78
Prepaid Expenses	102.79	58.91	71.41	21.39	15.49	8.16
Other Current Assets	23.66	333.62	60.91	1,267	847.87	173.93
Total Current Assets	15,068	9,843	8,576	31,154	24,092	25,607
Property, Plant & Equipment	5,817	6,240	6,608	6,748	6,029	7,011
Long-Term Investments	-0	0	0	-0	0	-
Other Intangible Assets	820.33	879.93	269.63	313.41	271.58	269.71
Long-Term Deferred Charges	2,950	3,278	3,933	4,589	5,244	5,900
Other Long-Term Assets	578.12	501.5	1,287	473.47	673.02	295.16
Total Assets	25,233	20,741	20,674	43,277	36,309	39,083
Accounts Payable	223.48	298.82	255.48	381.91	296.57	601.76
Short-Term Debt	2,186	2,014	-	18,692	18,399	17,386
Current Portion of Leases	1.77	1.69	1.56	1.43	-	-
Other Current Liabilities	3,357	3,396	872.49	811.14	1,395	919.8
Total Current Liabilities	5,769	5,711	1,130	19,886	20,091	18,907
Long-Term Leases	1.33	2.24	3.93	5.49	-	-
Other Long-Term Liabilities	30	30	206.41	116.22	77.31	-
Total Liabilities	8,402	8,175	3,454	22,179	22,098	20,657
Common Stock	5,707	5,339	5,339	5,336	4,821	4,821
Additional Paid-In Capital	61,031	57,402	57,402	57,371	47,840	47,840
Retained Earnings	-50,609	-50,876	-46,210	-42,062	-38,680	-34,436
Comprensive Income & Other	700.82	700.82	688.64	452.86	229.89	201.9
Total Common Equity	16,831	12,566	17,219	21,098	14,211	18,426
Shareholders' Equity	16,831	12,566	17,219	21,098	14,211	18,426
Total Liabilities & Equity	25,233	20,741	20,674	43,277	36,309	39,083
Total Debt	2,189	2,018	5.49	18,699	18,399	17,386
Net Cash (Debt)	3,058	-1,823	834.79	5,402	290.4	6,977
Net Cash Growth	-	-	-84.55%	1760.05%	-95.84%	-45.30%
Net Cash Per Share	280.95	-170.76	78.21	528.69	30.13	723.69
Filing Date Shares Outstanding	11.41	10.68	10.68	10.67	9.64	9.64
Total Common Shares Outstanding	11.41	10.68	10.68	10.67	9.64	9.64
Working Capital	9,300	4,132	7,447	11,267	4,001	6,700
Book Value Per Share	1474.48	1176.85	1612.67	1976.95	1473.91	1911.10
Tangible Book Value	16,010	11,686	16,950	20,784	13,940	18,157
Tangible Book Value Per Share	1402.61	1094.44	1587.42	1947.58	1445.75	1883.13
Land	1,174	1,174	1,174	1,174	1,004	1,132
Buildings	3,909	3,909	3,909	3,909	3,456	3,857
Machinery	11,333	11,545	11,434	10,381	9,811	9,368
Construction In Progress	125.36	125.36	-	332.66	1.11	98.09

Source: S&P Capital IQ. Standard template. Financial Sources.